Actively Recruiting

All Genders
Healthy Volunteers
ID00807482

Diagnostic and Clinical Characterization of Patients With Unusual Genetic Disorders of the Airways

Led by University of North Carolina, Chapel Hill · Updated on 2025-05-23

1800

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of North Carolina, Chapel Hill

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research focuses on primary ciliary dyskinesia (PCD), a genetic disorder that impairs the function of respiratory cilia, leading to lung disease. The study aims to identify key genes involved in normal ciliary function and understand how genetic mutations cause PCD and contribute to other common airway diseases like asthma and chronic obstructive pulmonary disease. The project seeks to improve diagnosis and insight into the genetic variability affecting ciliary function. The study is observational and involves identifying genetic mutations in patients with PCD, including those with unusual ciliary structures or functions. Researchers analyze the ultrastructure, wave form, and beat frequency of cilia to correlate genetic mutations with ciliary abnormalities. They study patients with typical and atypical PCD presentations, including those with normal ciliary ultrastructure but abnormal function, using family-based and proteomic approaches. Participants include people diagnosed with PCD or healthy volunteers with a family member diagnosed with PCD. The study involves detailed clinical characterization and genetic analysis but does not involve any treatment interventions. Researchers aim to understand the relationship between mutations and ciliary function, which may help diagnose PCD better and explore its role in other airway diseases. This study is ongoing, with participation involving genetic and clinical evaluations over time.

CONDITIONS

Brief Title

Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who have a high suspicion for the diagnosis of PCD, based on clinical features
  • Healthy volunteers who have a family member with confirmed PCD
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - Ongoing throughout the study period

Participants undergo clinical and genetic assessments to identify mutations and characterize ciliary function related to primary ciliary dyskinesia (PCD).

Long-term Monitoring

Duration - Up to several years

Participants are observed over time to correlate genetic findings with clinical features and disease progression.

Trial Site Locations

Total: 1 location

1

The University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Swiss Primary Ciliary Dyskinesia Registry for Patients in Sw...

Primary Ciliary Dyskinesia

Actively Recruiting

1 location

The Ear-Nose-Throat (ENT) Prospective International Cohort o...

Primary Ciliary Dyskinesia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia.

Marcus P Kennedy, Heymut Omran, Margaret W Leigh...

https://pubmed.ncbi.nlm.nih.gov/17515466

Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: implications for application to clinical testing.

Jonathan S Berg, James P Evans, Margaret W Leigh...

https://pubmed.ncbi.nlm.nih.gov/21270641

Founder mutation in RSPH4A identified in patients of Hispanic descent with primary ciliary dyskinesia.

M Leigh Anne Daniels, Margaret W Leigh, Stephanie D Davis...

https://pubmed.ncbi.nlm.nih.gov/23798057